The Microbiota Promotes Arterial Thrombosis in Low-Density Lipoprotein Receptor-Deficient Mice. by Kiouptsi, Klytaimnistra et al.
The Microbiota Promotes Arterial Thrombosis in Low-Density
Lipoprotein Receptor-Deﬁcient Mice
Klytaimnistra Kiouptsi,a Sven Jäckel,a,b Giulia Pontarollo,a Alexandra Grill,a,b Marijke J. E. Kuijpers,c Eivor Wilms,a
Christian Weber,d,e Felix Sommer,f Magdolna Nagy,c Carlos Neideck,c,d Yvonne Jansen,d Stefanie Ascher,a
Henning Formes,a Cornelia Karwot,a Franziska Bayer,a Bettina Kollar,a Saravanan Subramaniam,a Michael Molitor,a,b,g
Philip Wenzel,a,b,g Philip Rosenstiel,f Hristo Todorov,h Susanne Gerber,h Ulrich Walter,a,b Kerstin Jurk,a,b
Johan W. M. Heemskerk,c Emiel P. C. van der Vorst,d,e Yvonne Döring,d,e,i Christoph Reinhardta,b
aCenter for Thrombosis and Hemostasis (CTH), University Medical Center Mainz, Mainz, Germany
bGerman Center for Cardiovascular Research (DZHK), Partner Site RheinMain, Mainz, Germany
cDepartment of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands
dInstitute of Cardiovascular Prevention, Department of Medicine, Ludwig-Maximilians-University Munich, Munich, Germany
eGerman Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany
fInstitute of Clinical Molecular Biology (IKMB), Kiel University, Kiel, Germany
gCenter for Cardiology, Cardiology I, University Medical Center Mainz, Mainz, Germany
hInstitute of Developmental Biology and Neurobiology, Johannes Gutenberg University of Mainz, Mainz, Germany
iDivision of Angiology, Swiss Cardiovascular Center, Inselspital, Bern University Hospital, Bern, Switzerland
ABSTRACT Atherosclerotic plaque development depends on chronic inﬂammation
of the arterial wall. A dysbiotic gut microbiota can cause low-grade inﬂammation,
and microbiota composition was linked to cardiovascular disease risk. However, the
role of this environmental factor in atherothrombosis remains undeﬁned. To analyze
the impact of gut microbiota on atherothrombosis, we rederived low-density lipo-
protein receptor-deﬁcient (Ldlr/) mice as germfree (GF) and kept these mice for
16 weeks on an atherogenic high-fat Western diet (HFD) under GF isolator condi-
tions and under conventionally raised speciﬁc-pathogen-free conditions (CONV-
R). In spite of reduced diversity of the cecal gut microbiome, caused by athero-
genic HFD, GF Ldlr/ mice and CONV-R Ldlr/ mice exhibited atherosclerotic
lesions of comparable sizes in the common carotid artery. In contrast to HFD-fed
mice, showing no difference in total cholesterol levels, CONV-R Ldlr/ mice fed
control diet (CD) had signiﬁcantly reduced total plasma cholesterol, very-low-
density lipoprotein (VLDL), and LDL levels compared with GF Ldlr/ mice. My-
eloid cell counts in blood as well as leukocyte adhesion to the vessel wall at the
common carotid artery of GF Ldlr/ mice on HFD were diminished compared to
CONV-R Ldlr/ controls. Plasma cytokine proﬁling revealed reduced levels of
the proinﬂammatory chemokines CCL7 and CXCL1 in GF Ldlr/ mice, whereas
the T-cell-related interleukin 9 (IL-9) and IL-27 were elevated. In the athero-
thrombosis model of ultrasound-induced rupture of the common carotid artery
plaque, thrombus area was signiﬁcantly reduced in GF Ldlr/ mice relative to
CONV-R Ldlr/ mice. Ex vivo, this atherothrombotic phenotype was explained
by decreased adhesion-dependent platelet activation and thrombus growth of
HFD-fed GF Ldlr/ mice on type III collagen.
IMPORTANCE Our results demonstrate a functional role for the commensal mi-
crobiota in atherothrombosis. In a ferric chloride injury model of the carotid artery,
GF C57BL/6J mice had increased occlusion times compared to colonized controls. In-
terestingly, in late atherosclerosis, HFD-fed GF Ldlr/ mice had reduced plaque
rupture-induced thrombus growth in the carotid artery and diminished ex vivo
thrombus formation under arterial ﬂow conditions.
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Atherosclerosis, a major burden of Western lifestyle-associated diseases, is a chronicinﬂammatory process of the vessel wall arising at sites of disturbed blood ﬂow. The
development of atherosclerotic plaques depends on hypercholesterolemia and has
been linked to low-grade inﬂammation-triggered by innate immune signaling (1). In
addition, infection can promote lesion progression, and many studies have linked
innate immunity as a possible cause of atherosclerosis (2–5). Since the gut microbiota
is an established factor shaping the host’s innate immunity response, its absence and
the composition of this densely colonized microbial ecosystem have been associated
with atherosclerosis and arterial thrombosis (6–13).
It is known that signaling through pattern recognition receptors profoundly inﬂu-
ences the development of atherosclerotic lesions (14). In the genetic apolipoprotein
E-deﬁcient (Apoe/) mouse model, lacking the Toll-like receptor (TLR) adaptor protein
Myeloid differentiation primary response 88 (MyD88), a reduction in lesion size was
noted (15). Likewise, Toll-like receptor 2 (Tlr2)-deﬁcient hypercholesterolemic Ldlr/
mice were shown to have only minimal lesions compared with wild-type (WT) Ldlr/
controls (16). Furthermore, Tlr4 deﬁciency in Apoe/ mice resulted in reduced aortic
atherosclerosis (17). In contrast, germfree (GF) Apoe/ mice carrying the lpsd allele,
thus being unable to respond to bacterial lipopolysaccharide (LPS), did not show an
altered lipid proﬁle and had similar levels of aortic cholesterol esters and aortic root
plaque size compared to their conventionally raised (CONV-R) controls (18). In spite of
the wealth of genetic mouse studies, the role of the commensal gut microbiota in
stimulating carotid artery atherosclerosis, the site where plaques frequently rupture
and embolize, causing stroke, remains poorly understood.
The variable composition of commensal microbiota has been suggested as an
environmental factor contributing to cardiometabolic disease states (6, 16), develop-
ment of atherosclerotic lesions (19, 20) and arterial thrombosis (11–13, 21). We have
recently demonstrated that GF mice are protected from angiotensin II-induced vascular
dysfunction and angiotensin II-induced hypertension, which could ultimately contrib-
ute to the development of atherosclerosis (22). In addition, carnitine and choline
nutrients that are metabolized by the commensal microbiota to yield proatherogenic
trimethylamine (23), as well as exogenous bacterial (24) and endogenous TLR ligands
(25) (e.g., HMGB-1) are considered to promote cardiovascular disease development. In
shotgun sequencing analyses of fecal samples from patients with symptomatic athero-
sclerosis, Collinsella was found to be enriched, whereas Roseburia and Eubacterium were
reduced (9). Although the commensal microbiota composition has emerged as a risk
factor for cardiometabolic disease (26), it remains controversial how the gut
metagenome contributes to the development of atherosclerosis (7, 18–20) and in
particular how the gut microbiota inﬂuences atherothrombotic processes, i.e., the
rupture of an atherosclerotic plaque at the carotid artery, with subsequent thrombus
formation.
The possible contribution of commensal microbiota to Western diet-induced carotid
artery atherosclerosis and plaque thrombogenicity in the Ldlr/ mouse model is
unknown. To explore whether the microbiota is involved in atherothrombosis, we
comparatively analyzed the plasma lipoprotein proﬁle, vascular inﬂammation, carotid
artery plaque size, extent of plaque rupture-induced thrombosis, and ex vivo platelet
adhesion to collagen under ﬂow in GF Ldlr/ and CONV-R Ldlr/ mice, receiving a
normal chow control diet (CD) or a high-fat Western diet (HFD) for 16 weeks, respec-
tively. Our results demonstrate that the commensal microbiota reduced plasma cho-
lesterol levels in CD-fed Ldlr/ mice, but not in HFD-fed Ldlr/ mice. The presence of
the microbiota in HFD-fed Ldlr/ mice did not affect late atherosclerotic lesion size at
the carotid artery but increased myeloid blood cell counts and platelet deposition to
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collagen coatings, associated with increased thrombus growth in the carotid artery
following ultrasound-induced plaque rupture.
RESULTS
Ldlr/ mice are a well-established model of familial hypercholesterolemia, charac-
terized by 2-fold higher plasma cholesterol levels compared to WT controls on a normal
CD (27). If subjected to a HFD, Ldlr/ mice show 10-fold-higher plasma cholesterol
levels, increased VLDL and LDL levels with atheroma formation in the aorta and
characteristic plaque formation at the aortic root (27). Since the role of commensal
microbiota on hypercholesterolemia and atherothrombosis is unresolved (19, 28), we
rederived CONV-R Ldlr/ mice as GF and kept this mouse line on a sterile gamma-
irradiated HFD at GF isolator conditions for 16 weeks to compare them with CONV-R
Ldlr/ control mice (sterility control; see Fig. S1 in the supplemental material).
Feeding Ldlr-deﬁcient mice with atherogenic diet alters gut microbial diversity.
HFD feeding was previously associated with dysbiosis that is characterized by a reduced
diversity of the gut microbiota (29, 30), resulting in decreased intestinal barrier function
and in the onset of a low-grade inﬂammatory state (20, 31). To monitor the inﬂuence
of HFD feeding, we compared the cecal microbiome composition of Ldlr/ littermates
on CD with mice that at the same age were fed with an atherogenic HFD for 16 weeks.
We noted vast changes in diversity between the groups (beta-diversity) (Fig. 1A). In
CONV-R Ldlr/ mice on HFD, the relative abundance of members of the taxa Clostri-
diaceae, Staphylococcaceae, Bacillales, Streptococcaceae, and Clostridales increased rel-
ative to mice fed CD, whereas Lactobacillaceae, Proteobacteria, and Betaproteobacteria
decreased (Fig. 1B; see Table S1). Generally, the bacterial richness of the cecal microbial
community was signiﬁcantly reduced by HFD feeding (Fig. 1C and D). Furthermore, the
ratio of Firmicutes to Bacteroidetes, the dominant bacterial divisions in the distal mouse
intestine (32), was signiﬁcantly increased in HFD-fed mice compared to CD-fed mice
(Fig. 1E and F; Fig. S2A). Collectively, these data demonstrate that in the Ldlr/ mouse
model, HFD feeding resulted in a dysbiotic cecal microbiota.
The gut microbiota modulates the plasma lipoprotein proﬁle with CD feeding
but does not alter lipoprotein composition or carotid artery atherosclerotic lesion
size on HFD. Next, we analyzed whether the microbial colonization state of the host
inﬂuences the composition of the lipoprotein proﬁle. Similar to Apoe/mice (7, 28), GF
Ldlr/ mice on CD had increased total plasma cholesterol levels compared with
CONV-R Ldlr/ mice (Fig. 2A). The higher total plasma cholesterol levels in GF Ldlr/
mice were reﬂected by signiﬁcantly increased VLDL and LDL cholesterol, along with
elevated cholesterol in high-density lipoprotein (HDL) particles. Intriguingly, this
microbiota-dependent effect on the plasma cholesterol levels and the lipoprotein
proﬁle was abolished when the Ldlr/ mice were fed atherogenic HFD for 16 weeks
(Fig. 2B).
Histological analyses of ﬁxed-frozen sections demonstrated that atherosclerotic
plaque areas in the hematoxylin-and-eosin-stained carotid artery were not altered
despite the absence of commensals in GF Ldlr/ mice compared to CONV-R Ldlr/
mice on HFD (Fig. 2C). Of note, we also did not observe altered plaque sizes or wall
thickness in the common carotid artery, as determined by high-frequency ultrasound
imaging (Fig. S3A to C). When stratiﬁed by sex, the relative plaque size of carotid artery
plaques was not different between male and female HFD-fed Ldlr/ mice (Fig. 2C).
Furthermore, the absolute atherosclerotic lesion size in the carotid arteries did not
differ between GF Ldlr/ and CONV-R Ldlr/ mice (Fig. 2D; Table S2).
To investigate whether age signiﬁcantly impacts atherosclerotic lesion size of the
Ldlr/ mice fed HFD for 16 weeks, we calculated the Pearson correlation between age
and plaque size in the carotid artery. Age did not signiﬁcantly correlate with absolute
plaque size in the carotid artery but affected the relative values (Fig. 2D and E). In order
to investigate whether relative plaque size in the carotid artery differs between GF
Ldlr/ and CONV-R Ldlr/ mice after adjusting for age differences, we performed an
analysis of covariance (ANCOVA) with group assignment and sex as factors and age as
Atherothrombosis in Germfree Ldlr/ Mice ®
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FIG 1 HFD feeding promotes microbiota dysbiosis in Ldlr/ mice as revealed by cecal 16S ribosomal DNA amplicon sequencing. (A) Principal coordinate
analysis reveals distinct separation in microbiota composition due to diet (P  0.003 for control diet [CD] versus high-fat diet [HFD]). LDLR, LDL receptor.
(B) Linear discriminant analysis (LDA score) effect size (LEfSe) highlights differentially abundant microbial taxa (CD versus HFD). (C and D) Reduced alpha
diversity in HFD versus CD using Chao richness (C) and Shannon entropy (D) metrics. (E) HFD-induced changes in microbiome composition on the phylum
level. (F) Firmicutes/Bacteroidetes ratio in CD and HFD samples. In panels A, C, D, and F, the sex of the mice fed CD (triangles) and HFD (circles) is color
coded (females [red] and males [blue]). In panels C, D, and F, means  standard errors of the means (SEM) (error bars) are shown for the groups.
Independent samples from mice fed HFD versus CD were compared by Student t tests, and values that were signiﬁcantly different are indicated by bars
and asterisks as follows: *, P  0.05; **, P  0.01; ****, P  0.0001.
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covariate. The effect of age was statistically signiﬁcant (F(1, 32)  7.002, P  0.0125).
However, there was no signiﬁcant difference between male and female animals (F(1, 32) 
0.48, P 0.493) and between CONV-R and GF mice (F(1, 32) 1.41, P 0.244) even after
adjusting for the effect of age. In conclusion, the age of Ldlr/mice inﬂuenced relative
plaque size, but the GF housing condition had no signiﬁcant inﬂuence on late athero-
sclerotic lesion size in the carotid artery after 16 weeks of HFD feeding.
Germfree Ldlr-deﬁcient mice on HFD show reduced vascular inﬂammation. To
assess the vascular inﬂammatory phenotype of the generated gnotobiotic mouse
model in late atherosclerosis, we next analyzed blood cell counts of GF Ldlr/mice on
HFD relative to CONV-R controls. Feeding on a HFD for 16 weeks increased white blood
cell counts in CONV-R Ldlr/ mice relative to GF Ldlr/ mice about 2-fold (Fig. 3A).
The distribution of CD45 cells revealed that the microbiota-dependent increase in
leukocyte counts in CONV-R Ldlr/ mice was most prominent in the myeloid lineage,
as shown for monocytes and neutrophils (2-fold increase) (Fig. 3B and C). In addition,
FIG 2 Familial hypercholesterolemia is increased in GF Ldlr/mice on control diet (CD), but both cholesterol levels and atherosclerotic lesion size in the carotid
artery are unchanged after 16 weeks on high-fat diet (HFD) for GF Ldlr/ and CONV-R Ldlr/ mice. (A and B) Total cholesterol level and fractioned cholesterol
levels (VLDL, LDL, and HDL) of GF Ldlr/ and CONV-R Ldlr/ mice on CD (8 CONV-R mice; 6 GF mice) (A) and HFD (9 mice/group) (B). For the chromatogram,
representative lipoprotein proﬁles detected in CONV-R (black lines) and GF (purple lines) mice are shown. OD, optical density. (C, left) Representative histology
images showing hematoxylin-and-eosin-stained sections of carotid artery plaques in GF and CONV-R Ldlr/ mice on HFD. Bars, 1 mm. (Right) Relative
atherosclerotic plaque size (as a percentage) of the carotid artery of GF (17 mice [9 females and 8 males]) and CONV-R (17 mice [10 females and 7 males]) Ldlr/
mice after 16 weeks on a HFD, split by sex. Means SEM (error bars) are shown for the groups. Independent samples were compared by Student t tests. Values
that were signiﬁcantly different are indicated by bars and asterisks as follows: *, P  0.05; **, P  0.01. Values that were not signiﬁcantly different (n.s.) are
indicated. (D and E) Correlation between age and the absolute plaque size (in square micrometers) (D) or relative plaque size (as a percentage) (E) at the carotid
artery. For all panels, data for CONV-R mice are shown as gray dots, and data for GF animals are shown as white dots. The sex of the mice is color coded as
follows: females in red and males in blue.
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lymphocyte numbers were slightly increased in HFD-fed GF Ldlr/ mice (Fig. 3D). In
contrast, platelet counts were unchanged (not shown). Consistent with the increased
myeloid cell numbers, an altered plasma cytokine proﬁle was detected, featuring
increased levels of monocyte-derived proinﬂammatory chemokines CCL7 (chemokine
[C-C motif] ligand 7) and neutrophil-derived CXCL1 (chemokine [C-X-C motif] ligand 1)
in CONV-R Ldlr/ mice, whereas the T-cell-related interleukins IL-9 and IL-27 were
reduced in CONV-R Ldlr/ mice relative to GF Ldlr/ mice (Fig. 3E). In line with
decreased plasma CCL7 and CXCL1 levels and reduced leukocyte counts quantiﬁed in
the HFD-fed GF Ldlr/ mice compared to HFD-fed CONV-R Ldlr/ mice, intravital
imaging of the carotid artery wall demonstrated that the number of adhering leuko-
cytes to the arterial endothelium of HFD-fed GF Ldlr/ mice was signiﬁcantly reduced
relative to CONV-R Ldlr/ controls (Fig. 3F). Thus, our data indicate that the microbiota
enhances vascular inﬂammation at the carotid artery of HFD-fed Ldlr/ mice.
The microbiota promotes carotid artery thrombosis. The gut microbiota is a
factor that promotes ligation injury-induced thrombosis in the carotid artery of
C57BL/6J mice on a normal chow diet (12). Interestingly, in the ferric chloride (FeCl3)
injury model of the common carotid artery, GF C57BL/6J mice kept on a CD also
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FIG 3 GF Ldlr/ mice show reduced vascular inﬂammation after 16 weeks on HFD. (A to D) Blood cell counts of total
leukocytes (18 or 19 mice/group) (A) and percentage of CD45 cells: monocytes (16 to 18 mice/group) (B), neutrophils (15
to 19 mice/group) (C), and lymphocytes (18 or 19 mice/group) (D) from GF and CONV-R Ldlr/mice on HFD for 16 weeks,
analyzed by ﬂow cytometry. Means  SEM (error bars) are shown for the groups. (E) Multiplex cytokine ELISA quantiﬁ-
cation of mouse plasma samples (6 to 16 mice/group). (F) Intravital epiﬂuorescence video microscopy of endothelial
adherent and rolling leukocytes (green) in the common carotid artery of GF and CONV-R Ldlr/mice on HFD for 16 weeks
(11 to 16 mice/group). Nucleated cells were visualized with acridine orange. Means  SEM are shown for the groups.
Independent samples were compared by Student t tests. Statistical signiﬁcance: *, P  0.05; **, P  0.01; ***, P  0.001.
For all panels, data for CONV-R mice are shown in gray, and data for GF animals are shown in white. For panels A to D,
the sex of the mice is color coded as follows: females in red and males in blue.
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showed reduced thrombus growth compared to CONV-R C57BL/6J controls, as shown
by signiﬁcantly prolonged occlusion times (846.7 54.5 s in GF mice relative to
635.1 43.8 s in CONV-R mice) (Fig. 4A). Likewise, also ex-GF mice that were colonized
for 14 days with a cecal gut microbiota from a CONV-R donor mouse (conventionally
derived) presented signiﬁcantly reduced occlusion times (639.6 64.5 s) compared to
GF mice (846.7 54.5 s) (data not shown). Our experimental data on GF wild-type
C57BL/6J mice indicate that the microbiota promotes arterial thrombus growth, but
whether the microbiota also supports thrombus growth in atherothrombosis, where
subendothelial matrix components from the ruptured atherosclerotic plaque come into
contact with platelets, is currently unknown.
To assess whether the inﬂuence of the gut microbiota on platelet reactivity (11, 21)
impacts atherosclerotic plaque thrombogenicity in vivo, we applied an established
ultrasound-induced plaque rupture model of the carotid artery plaque, resulting in local
collagen exposure (33, 34). Importantly, we found that following ultrasound-induced
plaque rupture, thrombus growth was reduced by approximately 60% in GF mice
compared to CONV-R Ldlr/ mice on a HFD (Fig. 4B). Collectively, our intravital
imaging results demonstrate that the presence of gut microbiota enhances ferric
chloride-induced carotid artery thrombosis in C57BL/6J mice on a CD and plaque
rupture-induced thrombus growth at the carotid artery plaque of late atherosclerotic
Ldlr/ mice.
The microbiota promotes adhesion-induced platelet activation in Ldlr-deﬁcient
mice receiving HFD. As collagen is the major platelet-activating constituent of ath-
erosclerotic plaques (35, 36), we wanted to pinpoint whether platelet adhesion of
HFD-fed GF Ldlr/ mice to collagen is reduced compared with HFD-fed CONV-R
Ldlr/ mice. For this purpose, we used an ex vivo microspot-based ﬂow chamber
model, allowing multiparameter assessment of thrombus formation upon whole-blood
perfusion over collagen type I and type III coatings, resulting in precise characterization
of the thrombotic process and the relevant platelet activation markers (37) (Fig. 5;
Fig. S5). Indeed, supporting the reduced thrombus growth in vivo, in this model of
arterial ﬂow-dependent thrombus formation in anticoagulated whole blood, HFD-fed
GF mice showed a reduced phosphatidylserine (PS)-positive surface area coverage on
type I and type III collagen compared to the blood of HFD-fed CONV-R Ldlr/ mice
(Fig. 5A to D). On type III collagen, a reduced thrombus contraction score, multilayer
score, and thrombus height were observed (Fig. 5C and E). Other parameters of platelet
adherence to type I and type III collagen, such as platelet deposition, morphological
score, and P-selectin surface area coverage were unchanged in this model (Fig. 5A and
FIG 4 Reduced FeCl3-induced carotid artery occlusion in GF C57BL/6J mice and reduced plaque rupture-induced thrombogenicity
in GF Ldlr/ mice. (A) Intravital epiﬂuorescence video microscopy of thrombus formation (DCF-stained platelets [green]) at 0, 6, and
12 min in the 10% FeCl3-injured common carotid artery of GF (12 mice) and CONV-R (13 mice) C57BL/6J wild-type mice (representative
images) with analysis of occlusion times. (B) Intravital epiﬂuorescence video microscopy of thrombus formation (Rhodamin B-stained
platelets [red]) in the common carotid artery of GF (7 mice) and CONV-R (13 mice) Ldlr/ mice on HFD after plaque rupture induced
by 5 min of ultrasound. Means  SEM are shown for the groups. Independent samples were analyzed by Student t tests. Statistical
signiﬁcance was indicated by asterisks as follows: *, P  0.05; **, P  0.01. For all panels, CONV-R mice are shown in gray, and GF
animals are shown as white dots.
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FIG 5 Standardized whole-blood ﬂow chamber analysis for platelet deposition on collagen type I (A) and
collagen type III (B). End-stage representative images of whole-blood platelet deposits after 3.5 min on
collagen type I (A), and collagen type III (B). (C) Subtraction heatmap of HFD-fed GF Ldlr/ mice (12
mice/group) compared to CONV-R Ldlr/ mice (11 mice/group) (not shown). The degree of reduction
relative to CONV-R Ldlr/ mice is indicated in green (see scale panel). The analyzed parameters are as
follows: 1, morphological score; 2, platelet surface area coverage; 3, thrombus contraction score; 4,
multilayer score; 5, thrombus surface area coverage; 6, phosphatidylserine exposure; 7, P-selectin
expression; 8, integrin IIb3 (GPIIbIIIa) activation. (D and E) Descriptive statistics of HFD-fed GF and
CONV-R Ldlr/mice on collagen type I (D) and collagen type III (E) are shown only for signiﬁcant results.
Means  SEM are shown for the groups. Independent samples were tested by Student t tests. Statistical
signiﬁcance is indicated as follows: *, P  0.05; ****, P  0.0001. For all panels, data for CONV-R mice are
(Continued on next page)
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B; Fig. S5). Of note, activation of the GPIIb/IIIa (integrin IIb3) was decreased on type
III collagen in platelets from GF Ldlr/ mice compared to CONV-R Ldlr/ mice when
fed CD (Fig. S6P), which is consistent with the defect of GF mice in integrin-dependent
static adhesion of platelets to laminin in CD-fed mice (12). The presence of gut
microbiota facilitates adhesion-induced platelet activation and ex vivo thrombus for-
mation primarily to the type III collagen in the HFD-fed Ldlr/ mice (Fig. 6).
DISCUSSION
Even if hypercholesterolemia is the major factor in the onset of atherosclerotic
plaques, the gut microbiota, an actuating variable of the innate immune response,
FIG 5 Legend (Continued)
shown as gray dots, and data for GF animals are shown as white dots. The sex of the mice is color coded
as follows: females in red and males in blue.
FIG 6 Effects of gut microbiota on late carotid artery atherosclerosis and atherothrombosis. (A) For this study, either GF or CONV-R Ldlr/ mice on a
conventional diet (CD) were fed for 16 weeks with a high-fat diet (HFD), thus resulting in the onset and progression of atherosclerosis. For CONV-R Ldlr/mice,
the HFD yielded a reduced diversity of the commensal microbiota, with an increase in the Firmicutes/Bacteroidetes ratio. Interestingly, when fed with a CD, GF
Ldlr/ mice presented higher cholesterol levels with respect to CONV-R counterparts. (B) After cholesterol accumulation, resulting from deposition of VLDL
and LDL lipoproteins, an atherosclerotic plaque presents a subendothelial lipid core with inﬁltrating leukocytes characterized by the accumulation of smooth
muscle cells (SMC) from the tunica intima and tunica adventitia of the blood vessels. Although the relative plaque sizes at the carotid artery were unchanged
between the two groups, GF animals showed altered vascular inﬂammatory parameters and immune cell populations. EC, endothelial cells. (C) During
atherothrombosis, the plaque rupture yields to platelet deposition to the exposed subendothelial collagen, and subsequently to a bloodstream-circulating
thrombus growing on the platelet plug. In this context, GF Ldlr/ mice fed with a HFD presented lower yields of plaque rupture, collagen adhesion, and
thrombus growth. Arterial occlusion time was increased in CD-fed GF C57BL/6J mice compared to CONV-R controls.
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could affect the progression of atherosclerosis and subsequent atherothrombosis.
Feeding Ldlr/ mice atherogenic HFD for 16 weeks resulted in a signiﬁcantly reduced
diversity of the cecal gut microbiota compared to feeding mice CD. In accordance with
previous reports, this resulted in a decrease of the Bacteroidetes phylum and an increase
in Firmicutes in the HFD group compared with littermate controls kept on a CD (38, 39).
Importantly, HFD feeding was linked to changes in the gut microbiota associated with
impaired intestinal barrier function and increased gut microbiota-dependent metabolic
endotoxemia (31).
Total plasma cholesterol, VLDL, LDL, and HDL cholesterol levels were unchanged in
CONV-R Ldlr/ mice compared to GF Ldlr/ mice after 16 weeks of HFD. Likewise, GF
and CONV-R HFD-fed Ldlr/ mice, receiving the same HFD for 2 weeks, did not show
differences in total cholesterol levels (40). However, with basal CD feeding conditions,
the absence of commensal microbiota evoked a striking increase in plasma cholesterol
levels in the GF Ldlr/ mice. Our data therefore indicate a spill-over of cholesterol
resulting from the HFD feeding, which may mask the bacterial effect. Our results on
increased plasma cholesterol levels in GF Ldlr/ mice relative to CONV-R Ldlr/ mice
fed CD are in accordance with a number of reports on increased free cholesterol levels,
as well as an increase in the concentration of cholesterol esters in GF Apoe/ C57BL/6J
mice (7, 28, 41). Thereby, our results demonstrate that the cholesterol-lowering effect
of the gut microbiota is not speciﬁc to the Apoe/ hyperlipidemia mouse model. This
could be due to enhanced microbiota-dependent cholesterol synthesis and reduced
bile acid synthesis (41). Indeed, it is most likely that the microbiota-dependent conver-
sion of primary to secondary bile acids plays a central role under steady-state conditions
(42). The involvement of the gut microbiome in the regulation of cholesterol levels is
further substantiated by a clinical study demonstrating that several bacterial taxa
correlated with plasma cholesterol levels in atherosclerotic patients (8). Based on our
ﬁndings, it will be interesting to dissect which speciﬁc members of the microbiota
promote cholesterol excretion and how their relative abundance can be modulated
through targeted dietary or probiotic intervention strategies. Coherent with previous
studies on GF Apoe/mice kept on hypercholesterolemic diet (7, 18, 28), we found the
absolute size of late atherosclerotic plaques in the carotid artery unchanged between
HFD-fed GF Ldlr/ mice and HFD-fed CONV-R Ldlr/ mice. Therefore, it will be
interesting to analyze in future work whether the microbiota modulates early athero-
sclerosis. Moreover, the commensal microbiota is composed of both pathogenic and
protective bacteria, which could also explain why the absence of microbiota did not
yield in signiﬁcant changes in the atherosclerotic lesion size.
Although the absolute size of the carotid artery lesions was not affected, we
observed signs of elevated low-grade inﬂammation in CONV-R Ldlr/ mice compared
to GF Ldlr/ mice fed HFD. This was indicated by increased white blood cell counts,
namely, neutrophils and monocytes, along with elevated plasma CCL7 and CXCL1
levels. In accordance, both CCL7 and its receptor CCR2, as well as CXCL1 have been
implicated in monocyte mobilization from the bone marrow in steady state and under
conditions of hyperlipidemia, respectively (43, 44). Nevertheless, this did not result in
increased lesional macrophage content in plaques of mice receiving 16 weeks of a HFD.
Furthermore, increased levels of T-cell-related IL-9 and IL-27 were detected in the
plasma of GF Ldlr/ mice. In the Ldlr/ mouse model, IL-27 had an inhibitory role on
atherogenesis as it inhibited bone marrow-derived cell activation in the arterial walls
(45). In contrast, IL-9 was functionally linked to aggravated atherosclerosis in Apoe/
mice by the induction of vascular cell adhesion molecule 1 expression (46). In line with
elevated myeloid blood cell counts, enhanced vascular inﬂammation was apparent by
intravital imaging of the luminal side of carotid artery plaques prior to ultrasound-
induced rupture, with substantially increased leukocyte accumulation. Interestingly, in
the Apoe/mouse atherosclerosis model, this vascular inﬂammatory phenotype in the
atheroma-prone regions of the carotid artery was demonstrated to depend on the
endothelial expression of the Notch effector recombination signal binding for immu-
noglobulin kappa J region (RBPJ) (47), but the microbiota-dependent impact on
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endothelial pathways promoting leukocyte adhesion in atherosclerosis needs further
investigation.
To investigate the impact of the gut microbiota in atherothrombosis, we exploited
ultrasound-induced carotid artery plaque rupture combined with intravital imaging of
thrombus growth (33). Our data revealed a marked reduction in thrombus size in the
HFD-fed GF Ldlr/ mice compared with their HFD-fed CONV-R Ldlr/ counterparts,
pointing to a stimulatory effect of the gut microbiota on experimental atherothrom-
bosis. This ﬁnding expands on previous work from our laboratory, demonstrating that
the presence of commensals promotes arterial thrombus growth in the ligation-injured
carotid artery (12). The role of the gut microbiota in arterial thrombosis is further
corroborated by our data with the carotid artery ferric chloride injury model, showing
a signiﬁcantly prolonged time course of thrombus growth in GF C57BL/6J mice relative
to CONV-R wild-type controls. To mimic physiological arterial ﬂow conditions, we
analyzed thrombus formation on collagen type I and type III, the major platelet-
activating matrix constituents of carotid artery plaques (35), with a sensitive standard-
ized whole-blood ﬂow chamber system to detect differences in thrombus growth and
adhesion-dependent platelet activation (37). Similar to our in vivo observations, we
found reduced thrombus height, contraction score, and multilayer score of thrombi
formed on type III collagen in the anticoagulated whole blood from HFD-fed GF Ldlr/
mice compared to HFD-fed CONV-R Ldlr/ mice. Exposure of phosphatidylserine was
likewise decreased on collagen type I and type III coatings, which is known to be
mediated via signaling of the collagen receptor glycoprotein VI (GPVI) (36, 48), a crucial
receptor for platelet adhesion and aggregate formation at the arterial injury site
(49–51). Since we uncovered a microbiota-dependent increase in adhesion-induced
platelet activation, it will be most interesting to study platelet GPVI signaling related to
phosphatidylserine exposure in the GF hyperlipidemic Ldlr/ mouse model.
In conclusion, our data demonstrate that the microbiota does not modulate late
absolute atherosclerotic lesion size in the carotid artery, thus supporting recent reports
using the Apoe/ mouse model (7, 18, 28). Here we conﬁrmed in the Ldlr/ mouse
hypercholesterolemia model that the gut microbiota reduces plasma cholesterol levels
with CD feeding, but not under HFD-induced hypercholesterolemia in the Ldlr/
mouse model (7, 28). Our results demonstrate that, despite not affecting the absolute
lesion area in the carotid artery, the commensal microbiota augments low-grade
inﬂammation in the vessel wall. Our results suggest that a diminished adhesion-
dependent platelet activation on type I and type III collagen causes reduced plaque
rupture atherothrombosis in the carotid artery of HFD-fed GF Ldlr/ mice. Future
experiments should provide mechanistic insights on how the gut microbiota interferes
with platelet-collagen interaction, the pivotal pathomechanism in arterial thrombosis.
MATERIALS AND METHODS
Animals. B6.129S7Ldlrtm1Her/J mice (Ldlr/ mice) (52) were purchased from The Jackson Labora-
tory (Bar Harbor, ME, USA). Ldlr/ mice were rederived as germfree (GF) by aseptic hysterectomy and
maintained as a GF mouse colony in sterile ﬂexible ﬁlm mouse isolator systems. The germfree status of
mice was tested weekly by PCR for detection of 16S rDNA and by bacterial culture. All experimental
animals were 9- to 29-week-old male or female mice housed in the Translational Animal Research Center
(TARC) of the University Medical Center Mainz under speciﬁc-pathogen-free (SPF, CONV-R) or GF
conditions in EU type II cages with two to ﬁve cage companions with standard autoclaved lab diet and
water ad libitum, 22°C 2°C room temperature, and a 12-h light/dark cycle. All groups of mice were sex
and age matched, and all mice were free of clinical symptoms. All procedures performed on mice were
approved by the local committee on legislation on protection of animals (Landesuntersuchungsamt
Rheinland-Pfalz, Koblenz, Germany; 23177-07/G12-1-100; 23177-07/G13-1-072, 23177-07/G16-1-013, and
23 177-07/A 18-1-005 OEW).
Treatment of mice. Ldlr/ mice were fed 16 weeks with an adjusted calories diet (42% kcal from
fat, 17.3% protein, 48.5% carbohydrates, 21.2% [wt/wt] fat, and 0.2% cholesterol; contains 34% [wt/wt]
sucrose) that had been vacuum packaged, irradiated, and microbial analyzed (catalog no. TD.88137;
Envigo, Venray, the Netherlands). Control mice were kept on an autoclaved control diet (catalog no.
5021-3; PMI Nutrition International).
Microbiota analysis. MiSeq 16S amplicon V4-V5 sequence data were analyzed using MacQIIME
v1.9.1 (http://www.wernerlab.org/software/macqiime) (53) as described previously (54, 55). Brieﬂy, all
sequencing reads were trimmed, keeping only nucleotides with a Phred quality score of at least 20, then
Atherothrombosis in Germfree Ldlr/ Mice ®
September/October 2019 Volume 10 Issue 5 e02298-19 mbio.asm.org 11
paired-end assembled, and mapped onto the different samples using the barcode information. Se-
quences were assigned to operational taxonomic units (OTUs) using uclust and the greengenes reference
database (gg_13_8 release) with 97% identity. Representative OTUs were picked and taxonomy assigned
using uclust and the greengenes database. Quality ﬁltering was performed by removing chimeric
sequences using ChimeraSlayer and by removing singletons and sequences that failed to align with
PyNAST. The reference phylogenetic tree was constructed using FastTree 2. All samples within a single
analysis were normalized by rarefaction to the minimum shared read count to account for differential
sequencing depth among samples (95,000 sequences per sample). Relative abundance was calculated by
dividing the number of reads for an OTU by the total number of sequences in the sample. Alpha diversity
measures were computed, and unweighted Unifrac beta diversity was calculated and visualized by
principal coordinate analysis. Signiﬁcance of differences in abundances of various taxonomic units
between control (CD) and HFD groups was calculated using t test, and P values were adjusted for
multiple testing using false-discovery rate (FDR) correction (q-value). Linear discriminant analysis (LDA)
effect size (LEfSe) was performed using the online tool available at http://huttenhower.sph.harvard.edu/
galaxy/.
Lipoprotein proﬁle analysis. Plasma samples were subjected to fast-performance liquid chroma-
tography (gel ﬁltration on Superose 6 column; GE Healthcare). Different lipoprotein fractions were
separated and evaluated based on ﬂowthrough time. Cholesterol levels were quantiﬁed using an
enzymatic assay (Cobas, Roche) according to the manufacturer’s protocol.
Analysis of carotid artery atherosclerotic lesion using histology. Lesion development in the left
common carotid artery was quantiﬁed by hematoxylin-and-eosin (H&E) staining of 4-m longitudinal
cryosections.
Hematologic analysis. EDTA anticoagulated mouse whole blood was collected from anesthetized
mice (5 mg/kg midazolam [5 mg of midazolam per kg of body weight], 0.5 mg/kg medetomidine,
0.05 mg/kg fentanyl), by intracardial puncture. Platelet and total and differential white blood cell counts
were determined using an automatic cell counter (ADVIA; Siemens, Erlangen, Germany).
Flow cytometry. Whole blood was collected in an EDTA-buffered tube, subjected to red blood cell
lysis, and centrifuged for 5 min at 300  g, and cell pellets were subsequently stained with different
antibody cocktails for analysis by ﬂow cytometry. Flow cytometry was conducted with a FACS Canto II,
using FACSDiva software (BD Biosciences). Cell populations were discriminated by the following antibody
cocktail: anti-CD45 (clone 30-F11; eBioscience), anti-CD115 (clone AFS98; eBioscience), anti-Gr1 (clone
RB6-8C5; Biolegend), anti-CD11b (clone M1/70; eBioscience), anti-B220 (clone RA3-6B2; eBioscience), and
anti-CD3 (clone 145-2C11; eBioscience). Cell populations and marker expression were gated using the
FlowJo analysis program (Treestar): leukocytes (CD45), neutrophils (CD45 CD115-Gr1high), monocytes
(CD45 CD11b CD115), and lymphocytes (CD45 CD3 and CD45 B220).
Cytokine analysis. Cytokine levels in mouse plasma samples were measured using the ProcartaPlex
Multiplex Immunoassay technology from Affymetrix (Affymetrix, eBioscience, ProcartaPlex Mouse Cyto-
kine & Chemokine Panel 1, 26-plex), according to the manufacturer’s protocol.
Preparation of platelets and leukocytes for intravital epiﬂuorescence microscopy. Mice were
anesthetized by intraperitoneal injection of a solution of midazolame (5 mg/kg body weight), medeto-
midine (0.5 mg/kg body weight), and fentanyl (0.05 mg/kg body weight). Citrated whole blood was
collected by intracardial puncture. Murine platelets were isolated and labeled with Rhodamin B (20 g/
ml). The labeled platelet suspension was adjusted to a ﬁnal concentration of 150 103 platelets/l, and
250 l of suspension was injected via a jugular vein catheter. Thrombus formation of murine platelets
was assessed by high-speed epiﬂuorescence microscopy 10 min after plaque rupture. To characterize
leukocyte adhesion and rolling in vivo, leukocytes stained with acridine orange (50 g/l; 100 l per
mouse; Sigma-Aldrich) were imaged.
Mouse common carotid artery thrombosis models. Plaque rupture and measurement of acute
thrombus formation were performed as described earlier (33). Ldlr/ mice were fed high-fat diet with
42% from fat for 16 weeks. After the mice were anesthetized by intraperitoneal injection of a solution of
midazolame (5 mg/kg; Ratiopharm GmbH, Ulm, Germany), medetomidine (0.5 mg/kg; Pﬁzer Deutschland
GmbH, Berlin, Germany), and fentanyl (0.05 mg/kg; Janssen-Cilag GmbH, Neuss, Germany), a polyethyl-
ene catheter (0.28-mm inner diameter [ID], 0.61-mm outer diameter [OD]; Smiths Medical Deutschland
GmbH, Grasbrunn, Germany) was implanted into the right jugular vein, and the right carotid artery was
dissected free from surrounding tissue. The animal was injected intravenously with Rhodamin B-labeled
platelets obtained from a donor mouse with the same genetic background, hygiene status, and feeding
procedure. A subset of mice were also injected with acridine orange for leukocyte staining.
The ferric chloride injury model was performed by placing a 1-mm2 ﬁlter paper that was soaked with
10% (wt/wt) FeCl3 solution for 3 min laterally to the common carotid artery (55). Prior to the ferric
chloride injury, the anesthetized mouse was infused with 5- (and 6-) carboxy-2=,7=-dichloroﬂuorescein
diacetate (DCF)-stained platelets (green), as previously described (12). Directly after 3 min, the ﬁlter paper
and any residuals were ﬂushed away with isotonic sodium chloride solution that was warmed to 37°C.
Then, the common carotid artery of the mouse was placed under the objective, and the resulting thrombus
formation was recorded until the artery was completely occluded by using a high-speed wide-ﬁeld Olympus
BX51WI ﬂuorescence microscope with a long-distance condenser and a 10 (numerical aperture [NA] of 0.3)
water immersion objective with a monochromator (MT 20E; Olympus Deutschland GmbH, Hamburg, Ger-
many) and a charge-coupled-device camera (ORCA-R2; Hamamatsu Photonics, Japan). The time to occlusion
of the FeCl3-injured common carotid artery was determined. If the carotid artery did not occlude within 45
min, the experiment was terminated. Videos were recorded before the application of the ﬁlter paper, directly
after removing the ﬁlter paper, and then at 3-min intervals.
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Intravital high-speed video epiﬂuorescence microscopy. Using intravital ﬂuorescence microscopy,
a plaque was selected, and a rupture was induced by ultrasound application using a VibraCell VCX130
processor (Sonics, Newtown, CT, USA) (33, 34). Measurements were performed with a high-speed
wide-ﬁeld Olympus BX51WI ﬂuorescence microscope using a long-distance condenser and a 10 (NA of
0.3) water immersion objective with a monochromator (MT 20E; Olympus Deutschland GmbH, Hamburg,
Germany) and a charge-coupled-device camera (ORCA-R2; Hamamatsu Photonics, Japan). For image
acquisition and analysis, the Realtime Imaging System eXcellence RT (Olympus Deutschland GmbH,
Hamburg, Germany) software was used. Thrombus formation was recorded as soon as possible by
capturing ﬂuorescent images for at least 10 min. For image analysis, a threshold level was set, and
thrombus area was measured.
Whole-blood thrombus formation and platelet adhesion under ﬂow. Experiments were per-
formed as described previously (56) with minor modiﬁcations. Glass coverslips (24 by 60 mm) were
coated with two microspots (0.5 l/spot) in the direction of the ﬂow: (i) collagen type III (100 g/ml;
Octapharma, Berlin, Germany) and (ii) collagen type I (100 g/ml; Nycomed Pharma, Munich, Germany).
The coated coverslips were blocked with modiﬁed Tyrode’s HEPES buffer (pH 7.45) (TH buffer) (5 mM
HEPES, 136 mM NaCl, 2.7 mM KCl, 2 mM MgCl2, 0.42 mM NaH2PO4) containing 1% bovine serum albumin
(BSA) and mounted in parallel plate ﬂow chambers.
Blood samples were collected by retro-orbital puncture of mice under isoﬂurane anesthesia into
40 M PPACK, 5 U/ml heparin, and 50 U/ml fragmin (ﬁnal concentrations) and perfused for 3.5 min, at
a wall shear rate of 1,000 s1, over the microspot coatings. The platelets were stained by 2 min after
perfusion with Tyrode’s HEPES buffer (pH 7.45) (5 mM HEPES, 136 NaCl, 2.7 mM KCl, 2 mM MgCl2, 0.42
NaH2PO4, 2 mM CaCl2, 1 mg/ml glucose, 1 U/ml heparin, and 1 mg/ml BSA), supplemented with ﬂuo-
rescein isothiocyanate (FITC)-labeled rat anti-mouse CD62P monoclonal antibody (MAb) (1:40) (Emfret
Analytics, Würzburg, Germany), phycoerythrin (PE)-labeled rat anti-mouse JON/A MAb (1:20) (Emfret
Analytics), and Alexa Fluor 647 (AF647)-labeled annexin A5 (1:200) (Invitrogen Life Technologies, Carls-
bad, CA, USA). Representative end-stage bright-ﬁeld microscopic images were taken from each mi-
crospot during staining. After 2 min of stasis, remaining labels were washed away by perfusion with
label-free Tyrode’s HEPES buffer, after which three representative end-stage ﬂuorescence images were
collected per microspot.
Microscopic images (1,360 by 1,024 pixels, 142 by 107 m, 8-bit) were recorded with an EVOS ﬂuo-
rescence microscope (Life Technologies, Carlsbad, CA, USA), equipped with green ﬂuorescent protein
(GFP), red ﬂuorescent protein (RFP), and Cy5 light-emitting diode (LED) cubes, and an Olympus 60 oil
immersion objective, basically as described previously (37). Recorded images were analyzed using
semiautomated scripts written in Fiji software (Laboratory for Optical and Computational Instrumenta-
tion at the University of Wisconsin—Madison, USA). This resulted in percentages of surface area coverage
(%SAC) of deposited platelets/thrombus (from bright-ﬁeld images) and of %SAC of platelet/thrombus
ﬂuorescence per ﬂuorescent label. In addition, bright-ﬁeld images were analyzed for a morphological
score (scale of 0 to 5), thrombus contraction score (scale of 0 to 3), and thrombus height (multilayer, scale
of 0 to 3) in comparison to reference images, to provide an indication of the overall size and height of
platelet aggregates on the microspots (37). Finally, the %SAC of multilayered thrombi was analyzed by
manual coloring in Fiji.
For each ﬂow run, parameter values from individual bright-ﬁeld and ﬂuorescence images were
averaged to obtain one value per parameter per microspot. These values were linearly normalized to a
scale from 0 to 10 per individual parameter. Gene effect heatmaps were obtained by subtracting the
normalized average values per parameter of GF mice minus CONV-R mice. Differences compared to
CONV-R mice were considered statistically signiﬁcant with P  0.05 (t test, two-sided, equal variance)
after correction for multiple comparisons, where required. Subtraction heatmaps were produced by
using the R package version 3.2.5 (www.r-project.org).
Statistical analysis. Data are presented as means  standard errors of the means (SEM). Statistical
calculations were performed with GraphPad Prism 5 (GraphPad Software Inc., San Diego, CA, USA) using
the independent samples Student’s t test to compare two groups and analysis of variance (ANOVA) with
Tukey post hoc test for more than two groups.
Availability of data and materials. Sequence ﬁles and metadata for all samples used in this study
have been deposited in the ENA database (https://www.ebi.ac.uk/ena) under the accession numbers
ERS2865886 to ERS2865897. The applied commands and the LDA effect size are provided as supple-
mental material (Text S1). Other data sets used and/or analyzed during the current study are available
from the corresponding author upon request.
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